← Back to Team

Pierre Legault

Board Chairman

In addition to serving as Chairman at Sitryx Therapeutics, Pierre currently serves as the Chairman of the Board at Amolyt Pharma, Artios Pharma, Bicycle Therapeutics and Poxel Pharma, is a Board Director at Syndax Pharmaceuticals and was recently Lead Director at Urovant Sciences. In the past, he was a Board Director at Armo Biosciences, Clementia, Tobira Therapeutics, NPS Pharmaceuticals, Forest Laboratories, Regado Biosciences, Iroko Pharmaceuticals, Cyclacel Pharmaceuticals, Eckerd Pharmacy, Nephrogenex (served as the Chairman and CEO) and others. From 2010 to 2012, Mr. Legault served as the CEO of Prosidion Ltd. and from 2009 to 2010, he served as the CFO and Treasurer of OSI Pharmaceuticals. Mr. Legault also served as the CEO of Eckerd Pharmacies and as Senior Executive Vice President and CAO of the Rite Aid Corporation. Between 1989 and 2005, he held various roles such as President, CEO and CFO at legacy companies of Sanofi group. Mr. Legault holds an M.B.A. in Marketing from McGill University and a Bachelor's degree from HEC (University of Montreal). He also studied at Harvard Business School and is a CPA.